苯巴比妥市場：依適應症、劑型、配銷通路、地區

Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2023年11月03日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年苯巴比妥的全球市場規模為15.8億美元，預計2030年將達22.3億美元，2023年至2030年複合年成長率為5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	15.8億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	5.00%	2030年市場規模預測	22.3億美元

圖 1. 2023 年苯巴比妥全球市場佔有率(%)，依地區分類

苯巴比妥是一種用於治療和預防癲癇發作的藥物。它的作用是控制大腦中引起癲癇發作的異常電活動。它是一種稱為抗驚厥藥或鎮靜劑的藥物。當焦慮或緊張時，它也可用於幫助放鬆和睡眠。這種藥物只能憑醫生處方箋才能使用。

長期使用該藥有風險。這包括身體使用和吸收某些營養素（例如鈣、B 群維生素、葉酸和維生素 D）的問題。它還可以降低血液中磷酸鹽的水平，磷酸鹽是一種對正常細胞功能很重要的電解質。長期使用這種藥物也可能導致甲狀腺激素問題。

市場動態

眾所周知，苯巴比妥可有效治療癲癇和癲癇。它被認為是治療多種類型癲癇發作的第一線藥物，特別是在資源有限的地區。該藥物有效阻止癲癇發作的能力刺激了市場需求和使用。

苯巴比妥的市場受到安全性較高、副作用較少的替代抗癲癇藥物供應的限制。隨著具有不同作用機制和適應症的新藥的開發，有更多用於治療癲癇和癲癇疾病的替代藥物。醫療保健負責人可能會選擇開立這些新藥而不是苯巴比妥，特別是在減少副作用和藥物交互作用很重要的情況下。

本研究的主要特點

本報告對全球苯巴比妥市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
本報告還揭示各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
本報告還提供有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
本報告根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球苯巴比妥市場的主要企業。
該報告的見解將幫助行銷人員和經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
全球苯巴比妥市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球苯巴比妥市場的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 1.58 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.00%	2030 Value Projection:	US$ 2.23 Bn

Phenobarbital is a medicine which is used to treat or prevent seizures. It works by regulating the abnormal electrical activity in the brain that causes seizures. It is a class of medications called anticonvulsants and sedatives. It is also sometimes used for to help a person relax or sleep when he/she is anxious or nervous. This medication is available only with a doctor's prescription.

There is risk associated with the use of this medication if it is used for a long time. These include problems with how the body uses or absorbs certain nutrients (e.g., calcium, B vitamins, folic acid, and vitamin D). It can also lower the blood levels of phosphate, an electrolyte that is important for normal cell function. Long-term use of this medication can also cause problems with thyroid hormones.

Market Dynamics

Phenobarbital is well-known for its effectiveness in the management of epilepsy and seizure disorders. It is regarded as a first-line treatment for several types of seizures, especially in areas with limited resources. The drug's ability to effectively stop seizures fuels demand for and use of it on the market.

The market for phenobarbital is constrained by the availability of substitute anti-epileptic medications with enhanced safety profiles and fewer adverse effects. There are additional alternatives for treating epilepsy and seizure disorders which is due to the development of new drugs with various mechanisms of action and focused indications. Especially, in situations when limiting adverse effects or drug interactions is important, healthcare practitioners may choose to prescribe these newer medications over phenobarbital.

Key features of the study:

This report provides an in-depth analysis of the global phenobarbital market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global phenobarbital market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Cipla Ltd., and Par Pharmaceutical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global phenobarbital market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phenobarbital market

Global Phenobarbital Market Detailed Segmentation:

By Indication
- Epilepsy
- Neonatal Seizures
By Dosage Form
- Tablets
- Capsules
- Injectables
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Phenobarbital Market
- Sanofi
- Pfizer Inc.
- Novartis AG
- Lundbeck A/S
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals
- Cipla Ltd.
- Par Pharmaceutical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of epilepsy
- Restraints
Availability of alternative anti-epileptic Drugs
Adverse effects and safety concerns
- Opportunities
Increasing prevalence of neonatal seizures
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Phenobarbital Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Phenobarbital Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Neonatal Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

6. Global Phenobarbital Market, By Dosage Form, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

7. Global Phenobarbital Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Phenobarbital Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
India
China
Japan
Australia
ASEAN
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa